87 related articles for article (PubMed ID: 18339052)
1. Cardiovascular disease-risk factors in middle-aged osteopaenic women treated with calcium alone or combined to three nutrients essential to artery and bone collagen.
Massé PG; Tranchant CC; Jougleux JL; Coburn SP; Cole DE
J Hum Nutr Diet; 2008 Apr; 21(2):117-28. PubMed ID: 18339052
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.
Marini H; Bitto A; Altavilla D; Burnett BP; Polito F; Di Stefano V; Minutoli L; Atteritano M; Levy RM; Frisina N; Mazzaferro S; Frisina A; D'Anna R; Cancellieri F; Cannata ML; Corrado F; Lubrano C; Marini R; Adamo EB; Squadrito F
Nutr Metab Cardiovasc Dis; 2010 Jun; 20(5):332-40. PubMed ID: 19631515
[TBL] [Abstract][Full Text] [Related]
3. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats.
Shehata M; Kamel MA
Endocr Regul; 2008 Jun; 42(2-3):69-75. PubMed ID: 18624609
[TBL] [Abstract][Full Text] [Related]
5. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.
Bassuk SS; Albert CM; Cook NR; Zaharris E; MacFadyen JG; Danielson E; Van Denburgh M; Buring JE; Manson JE
J Womens Health (Larchmt); 2004; 13(1):99-117. PubMed ID: 15006283
[TBL] [Abstract][Full Text] [Related]
6. Dietary intervention with emphasis on folate intake reduces serum lipids but not plasma homocysteine levels in hyperlipidemic patients.
Lim HJ; Choi YM; Choue R
Nutr Res; 2008 Nov; 28(11):767-74. PubMed ID: 19083486
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
8. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
[TBL] [Abstract][Full Text] [Related]
9. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
10. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
11. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
12. Association between cholesterols, homocysteine and silent brain infarcts.
Oncel C; Demir S; Güler S; Cenikli U; Tabak E; Kiroğlu Y
Intern Med J; 2009 Mar; 39(3):150-5. PubMed ID: 19383063
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland.
Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
Eur J Intern Med; 2009 Jul; 20(4):373-7. PubMed ID: 19524177
[TBL] [Abstract][Full Text] [Related]
14. Changes in body composition following a dietary and lifestyle intervention trial: the postmenopausal health study.
Manios Y; Moschonis G; Koutsikas K; Papoutsou S; Petraki I; Bellou E; Naoumi A; Kostea S; Tanagra S
Maturitas; 2009 Jan; 62(1):58-65. PubMed ID: 19118956
[TBL] [Abstract][Full Text] [Related]
15. Effects of supplementation with a calcium-rich marine-derived multi-mineral supplement and short-chain fructo-oligosaccharides on serum lipids in postmenopausal women.
Cronin BE; Allsopp PJ; Slevin MM; Magee PJ; Livingstone MB; Strain JJ; McSorley EM
Br J Nutr; 2016 Feb; 115(4):658-65. PubMed ID: 26669430
[TBL] [Abstract][Full Text] [Related]
16. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women.
Rios DR; Rodrigues ET; Cardoso AP; Montes MB; Franceschini SA; Toloi MR
Nutrition; 2008; 24(11-12):1153-8. PubMed ID: 18842392
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
[TBL] [Abstract][Full Text] [Related]
18. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
Clifton PM; Bastiaans K; Keogh JB
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):548-54. PubMed ID: 19179060
[TBL] [Abstract][Full Text] [Related]
19. Effects of exercise vs bisphosphonates on bone mineral density in breast cancer patients receiving chemotherapy.
Swenson KK; Nissen MJ; Anderson E; Shapiro A; Schousboe J; Leach J
J Support Oncol; 2009; 7(3):101-7. PubMed ID: 19507458
[TBL] [Abstract][Full Text] [Related]
20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
